Hong Kong stock market reacts differently | WuYu-B (02256.HK) rose nearly 7% in early trading. The company will release the Phase II clinical trial data of the combination therapy of ipatasertib and liver cancer.

According to the Securities Times APP, Hony Capital's stock, code 02256.HK, rose by nearly 7% in early trading. As of the time of reporting, it had risen by 6.03% to 7.74 Hong Kong dollars, with a turnover of 4.9034 million Hong Kong dollars.